IMMUNE STATUS IN PATIENTS WITH ACQUIRED HEART DEFECTS AND ITS IMPACT ON THE CLINICAL COURSE OF THE DISEASE
Scientific and Innovative Therapy · 2026 · 5 (2) · 464-478
DOI: 10.64582/ivit.uz.690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2026. Verfasst von Diloram Nurimova.
Abstract (Originalsprache)
The development of clinical immunology today allows the widespread use of immunological methods in the diagnosis of various pathological conditions, it is no secret that the determination of cellular, humoral and non-specific factors of the immune system is used in the diagnosis of various nosological entities. In these pathological conditions, the quantitative and qualitative changes in specific and non-specific resistance factors of the immune system are not only diagnostic, but also prognostic.
Zitieren
APA
Nurimova, D. (2026). IMMUNE STATUS IN PATIENTS WITH ACQUIRED HEART DEFECTS AND ITS IMPACT ON THE CLINICAL COURSE OF THE DISEASE. Scientific and Innovative Therapy, 5(2), 464-478. https://doi.org/10.64582/ivit.uz.690
Vancouver
Nurimova D. IMMUNE STATUS IN PATIENTS WITH ACQUIRED HEART DEFECTS AND ITS IMPACT ON THE CLINICAL COURSE OF THE DISEASE. Scientific and Innovative Therapy. 2026;5(2):464-478. doi:10.64582/ivit.uz.690
BibTeX
@article{Nurimova2026,
author = {Nurimova, Diloram},
title = {IMMUNE STATUS IN PATIENTS WITH ACQUIRED HEART DEFECTS AND ITS IMPACT ON THE CLINICAL COURSE OF THE DISEASE},
journal = {Scientific and Innovative Therapy},
year = {2026},
volume = {5},
number = {2},
pages = {464--478},
doi = {10.64582/ivit.uz.690}
}
EUVIMED